Diese Liste ist eine Analyse basierend auf aktuellen Marktereignissen. Sie ist keine Anlageempfehlung.
Über
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides CombHeliX FSHD probes for the diagnosis of facioscapulohumeral dystrophy; FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur; and development agreement with Integrated Technologies Ltd for the design and development of a high-throughput scanning instrument for molecular combing assays. The company was founded in 2004 and is headquartered in Bagneux, France.
Je nach Börse kann das Aktiensymbol variieren. Zum Beispiel werden Genomic Vision-Aktien an der Börse Boerse Muenchen unter dem Symbol G09.MU gehandelt.
Wie viele Mitarbeiter hat Genomic Vision?▼
Stand 1. November 2026 hat das Unternehmen 27 Mitarbeitende.
In welchem Sektor ist Genomic Vision tätig?▼
Genomic Vision ist im Sektor Gesundheit & Wellness tätig.
Wann hat Genomic Vision einen Split durchgeführt?▼
Genomic Vision hatte in letzter Zeit keine Splits.
Wo hat Genomic Vision seinen Hauptsitz?▼
Der Hauptsitz von Genomic Vision befindet sich in Bagneux, Frankreich.